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Abstract
Background: Although the definition of multimorbidity as “the simultaneous presence of two or more chronic diseases” is well established, 
its operationalization is not yet agreed. This study aims to provide a clinically driven comprehensive list of chronic conditions to be included 
when measuring multimorbidity.
Methods: Based on a consensus definition of chronic disease, all four-digit level codes from the International Classification of Diseases, 10th 
revision (ICD-10) were classified as chronic or not by an international and multidisciplinary team. Chronic ICD-10 codes were subsequently 
grouped into broader categories according to clinical criteria. Last, we showed proof of concept by applying the classification to older adults from 
the Swedish National study of Aging and Care in Kungsholmen (SNAC-K) using also inpatient data from the Swedish National Patient Register.
Results: A disease or condition was considered to be chronic if it had a prolonged duration and either (a) left residual disability or worsening 
quality of life or (b) required a long period of care, treatment, or rehabilitation. After applying this definition in relation to populations of 
older adults, 918 chronic ICD-10 codes were identified and grouped into 60 chronic disease categories. In SNAC-K, 88.6% had ≥2 of these 60 
disease categories, 73.2% had ≥3, and 55.8% had ≥4.
Conclusions: This operational measure of multimorbidity, which can be implemented using either or both clinical and administrative data, 
may facilitate its monitoring and international comparison. Once validated, it may enable the advancement and evolution of conceptual and 
theoretical aspects of multimorbidity that will eventually lead to better care.
Keywords: Chronic disease—Epidemiology—International Classification of Diseases
Multimorbidity, or the coexistence of multiple chronic conditions 
in one person, is one of the main challenges facing health systems 
worldwide. It has an adverse multiplicative effect on all health 
outcomes (1). Multimorbidity also represents a challenge for medical 
services that often provide highly specialized care focused on single 
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Although the study of multimorbidity has attracted increasing 
levels of attention during the past two decades, its epidemiologi-
cal assessment and measurement is still identified as an area with 
important knowledge gaps, and filling these gaps remains a priority 
within the global research agenda (3). In particular, although the 
definition of multimorbidity as “the simultaneous presence of two 
or more chronic diseases” (4) is well established and accepted by the 
scientific community, the identification of which, how many, and in 
what manner diseases should be assessed in order to measure multi-
morbidity is still a matter of debate. As a result of the lack of explicit 
disease selection criteria, the number of conditions and specific diag-
noses considered in the multimorbidity literature are very diverse. In 
a systematic review of multimorbidity indices, the number of differ-
ent conditions ranged from 4 to 102 across the 39 indices identified 
(5). This leads to great heterogeneity not only in terms of prevalence 
estimates (ranging from 55% to 98% in older persons) (6) but also 
regarding the patterns of chronic disease co-occurrence (with up to 
97 different patterns composed of two or more diseases) (7).
Two major aspects have impeded the evolution of a more 
precise and universally accepted operational measure of multi-
morbidity. First, a clear definition of chronic disease is lacking in 
most studies. In some cases, diseases tend to be selected accord-
ing to predefined criteria such as their prevalence (8), the risk for 
adverse outcomes (9), or the treatability of the conditions (10). 
But it is also common that researchers determine their list based 
on pragmatic reasons, such as the availability of data (11), without 
further explanation. Second, establishing the level of disease cat-
egorization is a challenge that further increases the variation in the 
number of conditions across studies. Although all existing chronic 
conditions should ideally be considered in order to avoid bias 
toward the most prevalent—instead of relevant—conditions, the 
double counting of disease entities with a similar pathophysiology 
can be questionable (12). For example, cancer can be counted as a 
unique condition or as individual malignancies separately, and the 
term “heart diseases” is often used to group angina, atrial fibrilla-
tion, and heart failure.
Although various approaches to assess and measure multimor-
bidity have been suggested (13–18), a standardized instrument 
adapted to the older population has not prevailed so far. The devel-
opment of a specific assessment tool is necessary to drive research 
that leads to improvements in prognosis, diagnosis, treatment, and 
care of older persons with multiple health conditions. Moreover, this 
will support researchers in increasing the comparability of their mul-
timorbidity data, both across countries and over time. If we aim to 
capture the complete constellation of chronic health problems affect-
ing the older population, the identification of such health problems 
should be based on the clinical assessment of a comprehensive clas-
sification of medical diagnoses following transparent criteria.
The aims of this study were to provide a clinically driven proce-
dure for the assessment and measurement of multimorbidity in the 
older population and to show proof of concept by applying it to a 
population-based cohort of adults aged 60 years and older.
Method
The following procedure was agreed by the study team: (a) defini-
tion of chronic disease and formulation of the inclusion criteria; (b) 
identification of the codes from the International Classification of 
Diseases, 10th revision (ICD-10) (19) that fulfilled such criteria; and 
(c) grouping of the selected ICD-10 codes into broader disease cat-
egories according to clinical criteria.
Definition of Chronic Disease
Based on a literature review of existing definitions of chronic disease 
across scientific papers and reports from international health organi-
zations (eg, World Health Oroganization, U.S. Department of Health 
and Human Services, Australian Institute of Health and Welfare, 
etc.), the following key features were identified and discussed con-
cerning their pertinence and suitability in older populations: dura-
tion (prolonged or lasting for a specified time), course (progressive, 
recurrent or steady), reversibility (of symptoms and of pathological 
alterations), treatment (pharmacological, nonpharmacological, and 
care setting), and consequences (disability, quality of life, etc.). An 
international and multidisciplinary team of physicians (R.J.F.M., 
F.M., A.M., L.F.) and epidemiologists (S.A., D.R., A.K.W.) with clini-
cal and research expertise in chronic diseases and multimorbidity 
took part in the discussions. As a result, a definition of chronic dis-
ease was established, in order to identify chronic ICD-10 codes.
Identification of Chronic ICD-10 Codes
All four-digit level codes from the ICD-10 system were classified 
as being chronic or not, according to the definition as derived ear-
lier. Two geriatricians (D.L.V., A.C.) and two general practitioners 
(L.A.G.F., C.C.S.) independently did the initial assessment, with the 
subsequent involvement of three other geriatricians (A.M., G.O., 
M.S.P.) in case of disagreement. The latter three geriatricians also 
confirmed their agreement to the entire final list of four-digit level 
chronic ICD-10 codes.
Grouping of Chronic Diseases Into Broader 
Categories
The same group of physicians clustered those chronic ICD-10 codes 
according to clinical criteria and relevance (pathophysiological path-
way, treatment, prognosis, and prevalence) in order to create broader 
disease categories. Whenever possible, the original ICD-10 coding 
hierarchical structure was followed. However, there were some 
exceptions. First, some ICD-10 codes were segregated from others 
belonging to the same nosographic group given their high preva-
lence or their specificity in terms of clinical characteristics, manage-
ment, and prognosis, leading to a new specific disease category. For 
instance, this was the case for diabetes, multiple sclerosis, or inflam-
matory bowel diseases, which were considered separately from other 
metabolic, autoimmune, or colitis-related diseases, respectively. 
Second, other codes were moved from one specific nosographic group 
to another given their higher clinical homogeneity with this second 
group. For example, chronic viral hepatitis was subtracted from the 
category “Chronic infectious diseases” and grouped together with 
“Chronic liver diseases.” Third, additional categories were created 
that included a heterogeneous range of infrequent codes with com-
mon body organ/system involvement, pathophysiology, or treatment 
approach (eg, “Ear, nose and mouth disorders,” “Other neurological 
conditions,” etc.). Fourth, certain codes were included in more than 
one category when their labels referred to more than one disease 
entity. Such was for instance the case of spondylosis with myelopa-
thy (“Dorsopathies” + “Other neurological disorders”) or varicose 
veins of lower extremities with ulcer (“Venous and lymphatic disor-
ders” + “Chronic ulcer of the skin”).
Proof of Concept
The feasibility of our procedure was verified using both clinical and 
administrative data for a population-based cohort of older adults: (a) 
baseline data collected in the Swedish National study of Aging and 
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Care in Kungsholmen (SNAC-K) (20) and (b) inpatient data from 
the Swedish National Patient Register (21) for baseline SNAC-K par-
ticipants. Both use ICD-10 as the medical diagnoses coding system.
The SNAC-K population consists of a geographically based sam-
ple of people aged 60 years and older living at home and in institutions 
in the Kungsholmen area of central Stockholm. Baseline examina-
tions were carried out from March 2001 through August 2004 on 
a sample of 3,363 people (73.3% participation rate). Participants 
underwent extensive face-to-face interviews, clinical examinations, 
and testing in order to comprehensively assess their physical, neu-
rological, psychiatric, and cognitive function. Physicians in SNAC-K 
made clinical diagnoses based on participant self-report, medical 
charts, anamnestic details, and information gathered from partici-
pants’ proxies, in order to increase the reliability of the diagnoses. 
All drugs used by SNAC-K participants were collected by the exam-
ining physician and coded according to the Anatomical Therapeutic 
Chemical (ATC) classification (22). Before the interview, participants 
were instructed to bring a list of currently used medications and for 
cognitively impaired persons, a proxy or caregiver was asked instead. 
If the person was living in a nursing home, information on medica-
tion use was collected from medical records. In SNAC-K, additional 
clinical, lab, and drug-related parameters complement physicians’ 
assessment for certain conditions (Supplementary Table 1).
The Swedish National Patient Register includes all inpatient care 
in Sweden since 1987 and, from 2001, it also includes specialized 
outpatient visits including day surgery and psychiatric care from 
both private and public care providers. The linkage with SNAC-K 
data is done using the personal identification number (23) once 
informed consent has been obtained from participants. The chronic 
ICD-10 codes registered 5 years previous to the SNAC-K baseline 
physician visit were included, both from the main and all nine pos-
sible secondary diagnoses.
Statistical Analysis
Prevalence rates and 95% confidence intervals of individual chronic 
conditions and of multimorbidity were calculated for the SNAC-K 
study population. The distribution of the number of chronic con-
ditions across sex and age groups was graphically represented. To 
that end, the 11 original baseline age cohorts from SNAC-K were 
grouped into four broader categories: 60–66, 72–78, 81–87, and 
90+. To account for the sampling design, sex and age-specific weights 
were applied. Finally, we calculated the number of people with two 
or more different ICD-10 codes within the same chronic disease 
category (eg, coexistence of renal calculosis and uterine prolapse 
in people with “Other genitourinary diseases”), in order to verify 
whether multimorbidity estimated with the disease categories would 
differ substantially from multimorbidity estimated with ungrouped 
individual ICD-10 codes.
Results
A disease or condition was considered to be chronic if it had a pro-
longed duration and either (a) left residual disability or worsening 
quality of life or (b) required a long period of care, treatment, or 
rehabilitation. By applying this definition in consideration of older 
populations, the group of physicians identified 918 one to four-digit 
level ICD-10 codes as chronic and grouped them into 60 chronic 
disease categories in a second phase (Supplementary Table 2).
When applying our operational measure of chronic disease to the 
SNAC-K cohort (mean age 74.6, SD 11.2; 46.9% 75 years or older; 
64.9% women; 5.7% institutionalized) and when considering both 
available data sources, 13 out of the 60 disease categories showed 
a prevalence >10%, 35 were between 1% and 10%, and 12 were 
<1% (Table 1). Only 3.2% of participants were free from any of the 
60 disease categories. One in every 10 participants was identified 
as having disease(s) in only one of the 60 disease categories, and 
88.6%, 73.2%, and 55.8% were identified as having diseases in ≥2, 
≥3, and ≥4 of the disease categories, respectively. The prevalence of 
almost all diseases slightly increased when we assessed their pres-
ence by complementing diagnoses from SNAC-K with hospital data 
(Supplementary Table  3), especially so for pancreas, biliary tract 
and gallbladder disorders (73.6% of all cases), chronic skin ulcers 
(66.7% of all cases), peripheral vascular disease (55.6% of all cases), 
and chronic infectious diseases (50%).
We verified in the SNAC-K cohort that the percentage of peo-
ple with two or more different ICD-10 codes within a given disease 
category was less than 1% of all persons presenting with that cat-
egory (data not shown). Therefore, there should not be a substantial 
underestimation of multimorbidity when using our list of 60 disease 
categories, rather than ungrouped individual ICD-10 disease codes 
in the calculation of multimorbidity.
The number of chronic disease categories increased with age, 
consistently among men and women (Figure 1). The range and heter-
ogeneity of the number of chronic disease categories was wide across 
all age groups. More than one third of the adults aged 90 years and 
older experienced chronic disease in seven or more disease categories.
Discussion
Multimorbidity, which primarily affects the older population, is 
still insufficiently understood from an epidemiological perspective 
(3). This is mainly due to the fact that no standard approach for its 
measurement exists so far. The selection of diseases across the mul-
timorbidity literature is generally based on discretional criteria and 
dependent on the data available, which hinders comparability and 
generalizability of results.
In this study, we aimed to reach a consensus on which diseases 
fulfill the definition of chronicity, and how to categorize them into 
a manageable number of categories, based on the clinical judgment 
and agreement among an international and multidisciplinary team 
of geriatricians, general practitioners, and epidemiologists. When 
applied to the SNAC-K population, using both clinical data col-
lected directly in SNAC-K and administrative data derived from 
the Swedish National Patient Register for that same population, the 
overall prevalence of multimorbidity was higher than that gener-
ally reported in primary care or even population-based studies (24), 
whether we measure it as the coexistence of two, three, or even four 
chronic conditions. This is largely due to the higher number of dis-
eases considered in our comprehensive inclusion list and the integra-
tion of several sources of data (ie, lab, drug, and hospital data). The 
low discriminative power of any of the employed cut-off points to 
capture the heterogeneity in older adults’ morbidity is in line with 
recent claims suggesting to measure multimorbidity as a continuous 
grading scale of medical health problems rather than as a dichoto-
mous yes/no phenomenon (25).
Strengths and Weaknesses
The transparency of the process used to develop this operational meas-
ure of chronic multimorbidity in older adults is one of the added val-
ues of the present methodology. Our definition of chronic disease is in 
accordance with most other approved definitions that also incorpo-
rate time, treatment, care, quality of life, and function-related aspects. 
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Other dimensions such as disease progression (26), reversibility (27), 
sequelae (28), and prognosis (29) have also been considered occa-
sionally, but we believe these would not add considerable accuracy 
to the criteria already used in this study. In fact, duration is the most 
common, and sometimes, the only criterion used to define chronic 
conditions (30).
The classification of ICD-10 codes according to their chronicity 
was done by an international team of geriatricians and general practi-
tioners; two of the medical specialties that are best trained and suited 
to holistically assess and manage older patients with multiple coexist-
ing chronic problems in the inpatient and outpatient settings (31).
Ours is among the most comprehensive lists of chronic condi-
tions for measuring multimorbidity provided thus far. The need 
for more simple and succinct tools for multimorbidity detection 
has been proclaimed by some authors, mainly for practical reasons 
related to data access and processing (5,32), prevalence being the 
main driver for disease prioritization (33). However, rare diseases 
such as Parkinson’s disease (with a prevalence less than 2% in adults 
aged 60 years and older) (34) undeniably represent a heavy burden 
for affected older individuals. This is the case for many conditions 
that are less likely to lead to hospitalization but which may still sig-
nificantly impact quality of life and other important outcomes.
The present classification may be thought of as a reference frame-
work for chronic disease identification in different data sources, and 
as such aims to offer the most extensive list possible on the basis of 
a validated international system of disease classification. Yet, the list 
could be subject to the selection or exclusion of specific conditions, 
depending on the aims of the study. In this regard, the miscellaneous 
categories related to other diseases of a given organ/system may add 
little value to those studies focused on the pathophysiology underly-
ing disease associations, but enable weighting for rare but relevant 
chronic health problems such as hydrocephalus, myasthenia gravis, 
or pneumoconiosis.
The ICD used in this article is the standard for defining and 
reporting diseases, symptoms, and risk factors across WHO mem-
ber states. Its most recent version (ICD-10) includes health problems 
that have not been classified as diseases traditionally, but which are 
long-standing and have an impact on individuals’ quality of life, such 
as developmental disorders, limb dysfunction, visual impairment, 
urinary incontinence, or behavioral problems (35). This contributes 
to making our methodology more usable for both patients and clini-
cians (36). The 11th version (ICD-11), to be finalized by 2018, will 
be comparable and consistent with ICD-10, so our list may be easily 
updated to guarantee its long-term use.
Table 1. Prevalence per 100 Population (P/100) and 95% CI of Chronic Disease Categories Considering All Available Data Sourcesa (N = 3,363) 
Chronic Disease P/100 95% CI Chronic Disease P/100 95% CI
Hypertension 68.8 67.1–70.4 Other cardiovascular diseasesb 3.7 3.1–4.5
Dyslipidemia 45.8 44.1–47.6 Neurotic, stress-related and somatoform diseases 3.2 2.6–3.9
Chronic kidney diseases 37.5 35.9–39.1 Other genitourinary diseasesb 2.8 2.2–3.5
Ischemic heart disease 16.7 15.4–18.1 Cardiac valve diseases 2.7 2.1–3.3
Anemia 13.7 12.5–15.1 Migraine and facial pain syndromes 2.5 2.0–3.1
Osteoarthritis and other degenerative joint diseases 13.2 12.0–14.5 Other psychiatric and behavioral diseasesb 2.3 1.8–2.9
Colitis and related diseases 13.2 12.0–14.5 Other neurological diseasesb 1.9 1.5–2.5
Deafness, hearing impairment 12.3 11.2–13.5 Sleep disorders 1.9 1.5–2.4
Heart failure 11.7 10.6–12.9 Bradycardias and conduction diseases 1.9 1.4–2.4
Obesity 11.2 10.1–12.3 Peripheral vascular disease 1.8 1.3–2.4
Thyroid diseases 11.1 10.0–12.3 Other metabolic diseasesb 1.7 1.3–2.3
Dementia 10.5 9.5–11.6 Peripheral neuropathy 1.6 1.2–2.2
Atrial fibrillation 10.3 9.2–11.4 Chronic pancreas, biliary tract and gallbladder diseases 1.5 1.1–2.0
Depression and mood diseases 9.4 8.4–10.5 Allergy 1.4 1.1–1.9
Solid neoplasms 9.0 8.0–10.1 Parkinson and parkinsonism 1.3 0.9–1.8
Diabetes 8.9 7.9–10.0 Other respiratory diseasesb 1.1 0.8–1.6
Cerebrovascular disease 8.5 7.5–9.6 Chronic ulcer of the skin 1.0 0.7–1.5
Osteoporosis 7.6 6.7–8.7 Epilepsy 1.0 0.7–1.4
Other musculoskeletal and joint diseasesb 7.1 6.2–8.2 Ear, nose, throat diseases 0.9 0.6–1.3
Dorsopathies 6.6 5.8–7.6 Inflammatory bowel diseases 0.9 0.6–1.3
Glaucoma 6.5 5.6–7.5 Hematological neoplasms 0.8 0.5–1.2
Cataract and other lens diseases 6.3 5.4–7.2 Venous and lymphatic diseases 0.8 0.5–1.2
Asthma 6.0 5.2–6.9 Schizophrenia and delusional diseases 0.7 0.5–1.1
Other eye diseasesb 5.4 4.6–6.3 Blood and blood forming organ diseases 0.5 0.3–0.9
COPD, emphysema, chronic bronchitis 5.2 4.4–6.0 Other digestive diseasesb 0.5 0.3–0.8
Autoimmune diseases 4.8 4.1–5.7 Chronic infectious diseases 0.3 0.2–0.6
Blindness, visual impairment 4.5 3.8–5.3 Chronic liver diseases 0.2 0.1–0.4
Esophagus, stomach, and duodenum diseases 4.5 3.8–5.3 Multiple sclerosis 0.1 0.0–0.2
Prostate diseases 4.3 3.6–5.1 Other skin diseasesb 0.1 0.0–0.2
Inflammatory arthropathies 4.1 3.5–4.9 Chromosomal abnormalities 0.0 —
2+ chronic diseases 88.6 87.6–89.5
3+ chronic diseases 73.2 71.8–74.5
4+ chronic diseases 55.8 54.2–57.4
Note: CI = confidence intervals; COPD = chronic obstructive pulmonary disease; SNAC-K = Swedish National study of Aging and Care in Kungsholmen. All 
prevalence rates are adjusted by sex and age-specific weights to account for the sampling design.
aSNAC-K data + inpatient data from the National Patient Register. bThese categories group all chronic diseases not included in the other system-specific catego-
ries. The list of diseases included in each category can be viewed in Supplementary Table 2.
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Complementing self- or clinician-rated disease assessments with 
drug, primary care (unavailable in this study), or hospital registry 
data has proved to provide more reliable estimates than those based 
on only a single source of information (24). This is especially rel-
evant when studying multimorbidity rather than single morbidity, 
because the likelihood of incompleteness may be higher with increas-
ing numbers of problems affecting an individual.
Still, some important limitations need to be made explicit and 
taken into consideration. The high degree of diagnostic specificity 
implicit under the ICD system may be relevant from the specialist 
care point of view, but is poorly adapted to the reality of primary 
care where episodes of care—instead of episodes of disease—are 
assessed (37). O’Halloran’s code-set of chronic conditions built 
around the International Classification of Primary Care (ICPC) (30) 
may adequately complement our list, although no disease aggrega-
tion was proposed by these authors, whose list comprises up to 129 
conditions. Furthermore, for studies relying on patient self-report, 
disease designations may need to be adapted to make them under-
standable, clear, and distinguishable to lay participants.
We assigned no weights to individual conditions, although the 
differing impact of multimorbidity depending on the severity of dis-
orders has been previously acknowledged (38). Weighting is particu-
larly useful if the purpose of the measurement is to predict future 
outcomes such as mortality, but lacks interest beyond the specific 
outcome it is developed for or when no specific outcome is prior-
itized. Although osteoarthritis has a major impact on quality of life 
but not on mortality, the opposite is true for a small myocardial 
infarction.
The presence, number, or even combination of chronic health 
conditions alone may be of little informative value as a measure of 
an older person’s general health status (39). Other dimensions such 
as physical and cognitive function or coping strategies need to be 
considered if the well-being of older adults is to be assessed holisti-
cally (40). Moreover, our list is applicable only to older populations 
and therefore excludes relevant conditions such as endometriosis or 
the polycystic ovarian syndrome. Although multimorbidity is also 
common in younger populations (41), the physiological and clinical 
specificity of this phenomenon among older people deserves separate 
attention.
Comparison with Previous Research
Our list includes all health problems recommended by Diederichs 
and colleagues (5) to be included as core chronic diseases, and it 
vastly surpasses the minimum number of 12 conditions suggested 
by Fortin and colleagues to study prevalence estimates (24). Each of 
our 60 chronic disease categories identified has been incorporated in 
at least one of the most cited chronic disease inclusion lists for mul-
timorbidity definitions (13–18). The broadness of our scope resulted 
in the inclusion of conditions, such as blood diseases, cataract and 
other lens diseases, chromosomal abnormalities, chronic infectious 
diseases, or chronic ulcers of the skin, which have so far only been 
considered by Salisbury and colleagues (17). The list published by 
these authors comprises 114 chronic conditions and is as yet the 
most exhaustive one, but it is part of a proprietary risk adjustment 
system whose algorithms are not available to the public. Other con-
ditions have exceptionally been included by other authors: allergy 
(15), autoimmune and connective tissue diseases (16), glaucoma (16), 
multiple sclerosis (16), peripheral neuropathy (14), and venous and 
lymphatic disorders (15). Still, there are a few diseases considered in 
other lists that we decided to exclude given their symptomatic nature 
(eg, dizziness) (15) or a lack of clear concordance with the definition 
of chronic disease (eg, pulmonary embolism, as an acute event rather 
than a chronic disease) (17).
Other classification schemes for identifying chronic conditions 
have been developed in the United States (42–45). Some were devel-
oped for measuring chronic multimorbidity in the general popu-
lation, but others for purposes such as the prediction of medical 
expenditures (42) or the evaluation of public health interventions 
(43). Compared with these, our operational measure of multimor-
bidity has the particularity of being specifically defined for older 
persons (ie, youth disorders such as autism (44) or attention-deficit/
hyperactivity disorders (45) were excluded). Furthermore, our classi-
fication was based on an ad hoc clinical assessment of medical diag-
noses by physicians and epidemiologists specialized in geriatrics and 
family medicine.
Future studies should analyze whether our proposed measure of 
multimorbidity outperforms these lists of chronic conditions regard-
ing their predictive value for adverse health outcomes and their use-
fulness for clinical management and treatment decision support.
Applicability of Results
The demographic of older adults continues to grow, and thus, per-
sons in this age range will continue to dominate health research in 
the coming decades. Therefore, a standardized comprehensive list 
of chronic conditions that can be pragmatically implemented using 
clinical and administrative data sources is necessary, in order to offer 
accurate, reproducible, and understandable information on time 
trends of the incidence and prevalence of multimorbidity. This will 
be crucial for the programing and forecasting of available health 
care resources in the future (46).
Moreover, if the greatest burdens of disability and death dur-
ing old age arise from the co-occurrence of chronic diseases (6), 
studying the determinants of chronic disease development and 
Figure 1. Percent distribution of number of chronic disease categories by sex 
and age group considering all available data sources (N = 3,363). Swedish 
National study of Aging and Care in Kungsholmen (SNAC-K) data + inpatient 
data from the National Patient Register. Within-age group prevalence rates 
are adjusted by age-specific weights to account for the sampling design.
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accumulation will become a priority. This will also be vital to ensure 
that the extra years accruing from longevity are lived in good health. 
An open-access, reference list of chronic diseases is a prerequisite 
for the design and execution of this type of observational research. 
Epidemiological studies, where chronic multimorbidity is likely to 
be a confounder or effect modifier, may also benefit from our meth-
odology (47).
Finally, one important step that is necessary in order to generate 
an evidence base for clinical practice in patients with multimorbid-
ity is the focus on the associations of chronic diseases into so-called 
patterns of multimorbidity (41). Knowledge about such patterns pro-
vides essential information for developing guidelines that offer clinical 
management and treatment decision support for patients with multi-
ple chronic diseases. However, unless a homogeneous list of chronic 
conditions is available, no contrastable information will be obtained 
from the myriad of disease associations identified across studies (7).
Conclusions
We provide a clinically driven comprehensive list of chronic con-
ditions that can be implemented using either or both clinical and 
administrative data. The list is openly available to the entire research 
community as a basis for discussion and to be validated in other 
populations. It may enable the advancement and evolution of con-
ceptual and theoretical aspects of multimorbidity that will eventu-
ally lead to better care for the vast number of older people suffering 
from the coexistence of multiple chronic conditions.
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